A Study to Determine the Effectiveness of Spinal Cord Stimulation for the Treatment of Refractory Angina Pectoris


About this study

The purpose of this study is to perform an in-depth review of pre-operative considerations and indications for spinal cord stimulation (SCS) for refractory angina pectoris (RAP), intraoperative findings, and postoperative reports of any adverse events and (secondarily) patient reports of effectiveness with this therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All Mayo Clinic-Rochester patients who have undergone spinal cord stimulation for chest pain, chest tightness, or angina between January 1, 2003 and September 11, 2018.

Exclusion Criteria: 

  • Any children, prisoners, adults lacking capacity to consent, or patients who have declined research authorization.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

William Mauck, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer